Operations Indicators, page-10

Hi @BigPoppaBear, @elpassive, and @AICp,
Thanks for the constructive inputs and feedback in shaping the investment thesis. Apparently, I misunderstood the Applyzer data and have sent a note to Applyzer to further clarify. Hence, finding #3 is not valid:
1. acceleration in implemented beds pushed forward to H1FY21
2. backlog increase by 5x from FY19 on contracted beds
3. strong traction on PainChek apps download
I was trying to find a leading indicator. @elpassive suggested tracking of their full-time PainChek manager and would be happy if you can educate me on how to go around this.

If I may share my working of the subscription revenue, I see the implemented beds as the revenue driver, and my finding is A$273k of revenue is delayed and pushed to H1FY21. Please take a look and happy to hear your inputs and feedback.

row 43 - implemented beds from slide #13, see below snapshot from Aug 2020 presentation.
row 44 - a simple monthly average based on row 43. For example, average monthly IB for Apr-Jun20 is 19,010 (24,435+13,584)/2
row 45 - an estimated subscription revenue based on $4/month/bed. For example, for the quarter of Jun20, the estimated revenue is 19,010 x $4 x 3 months = $228,114
row 47 - an estimated subscription revenue for 6 months. As at Dec 2019, the estimated subs. revenue of $149,256 'matched' the reported subscription revenue of $152,873. There was no delay in implementation.
row 49 - $273k estimated subs. revenue delay to FY21.